TELA Bio, Inc. TELA
0.84 USD +0.04 (+4.46%)
At closeNov 4, 2026, 4:00 PM EST
0.80 -0.04 -4.27%
After hours · Nov 4, 4:00 PM ET
0.7801 Day range 0.92
0.501 52-week range 1.50
- YTD
- -29.00%
- 1 year
- -35.05%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 9.20 +998.1% upside
Now 0.8378
- Target (low)
- 5.00
- Target (mean)
- 9.20
- Target (high)
- 12.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy2
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.222 | -0.29 – -0.16 | -0.53 | +58.1% | 23.17M | +36.3% | 5 |
| Next quarter | -0.22667 | -0.30 – -0.16 | -0.5387 | +57.9% | 21.05M | +26.8% | 3 |
| Current year | -1.42 | -1.70 – -1.29 | -2.04 | +30.4% | 74.72M | +27.8% | 5 |
| Next year | -0.6375 | -0.87 – -0.45 | -1.42 | +55.1% | 93.78M | +25.5% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 4, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 13, 2024 | Lake Street | Maintained | Buy | Buy |
| Aug 13, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 13, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 13, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 25, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 10, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Mar 22, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 22, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Dec 27, 2023 | Lake Street | Reiterated | Buy | Buy |
| Nov 10, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Mar 28, 2023 | Canaccord Genuity | Reiterated | — | Buy |
| Mar 22, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Nov 10, 2022 | JMP Securities | Maintained | — | Market Outperform |
| Nov 10, 2022 | Piper Sandler | Maintained | — | Overweight |
| Aug 13, 2020 | Piper Sandler | Maintained | — | Overweight |
| Jul 9, 2020 | Jefferies | Maintained | — | Buy |
| Jun 18, 2020 | JMP Securities | Maintained | — | Market Outperform |
| Jun 10, 2020 | Canaccord Genuity | Maintained | — | Buy |
| May 13, 2020 | JMP Securities | Maintained | — | Market Outperform |
| Dec 3, 2019 | Jefferies | Initiated | — | Buy |
| Dec 3, 2019 | JMP Securities | Initiated | — | Market Outperform |
| Dec 3, 2019 | Piper Sandler | Initiated | — | Overweight |
| Dec 3, 2019 | Canaccord Genuity | Initiated | — | Buy |